https://images.mktw.net/im-62450483
Last Updated:
First Published:
Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted.
At the closing bell, BioAge’s stock
BIOA stood at $18.31 for a 1.7% gain over its IPO price. Earlier, the stock had been up as much as 30%.
This post was originally published on Market Watch
